Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients

by Kjersti Tjensvoll, Oddmund Nordgård, Maren Skjæveland, Satu Oltedal, Emiel A. M. Janssen, Bjørnar Gilje
Published 2019-11-01

Panoptic View of Prognostic Models for Personalized Breast Cancer Management

by Geetanjali Saini, Karuna Mittal, Padmashree Rida, Emiel A. M. Janssen, Keerthi Gogineni, Ritu Aneja
Published 2019-09-01

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer

by Ivar Skaland, Emiel A. M. Janssen, Einar Gudlaugsson, Lydia Hui Ru Guo, Jan P. A. Baak
Published 2009-01-01

Automatic Diagnostic Tool for Predicting Cancer Grade in Bladder Cancer Patients Using Deep Learning

by Rune Wetteland, Vebjorn Kvikstad, Trygve Eftestol, Erlend Tossebro, Melinda Lillesand, Emiel A. M. Janssen, Kjersti Engan
Published 2021-01-01

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer

by Håvard Søiland, Kjetil Søreide, Emiel A. M. Janssen, Hartwig Körner, Jan P.A. Baak, Jon Arne Søreide
Published 2007-01-01

Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis

by Hemendra Ghimire, Chakravarthy Garlapati, Emiel A. M. Janssen, Uma Krishnamurti, Gengsheng Qin, Ritu Aneja, A. G. Unil Perera
Published 2020-06-01

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.

by Kristin Jonsdottir, Jörg Assmus, Aida Slewa, Einar Gudlaugsson, Ivar Skaland, Jan P A Baak, Emiel A M Janssen
Published 2014-01-01

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas

by Vebjørn Kvikstad, Ok Målfrid Mangrud, Einar Gudlaugsson, Ingvild Dalen, Hans Espeland, Jan P. A. Baak, Emiel A. M. Janssen
Published 2019-08-01

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.

by Ok Målfrid Mangrud, Rune Waalen, Einar Gudlaugsson, Ingvild Dalen, Ilker Tasdemir, Emiel A M Janssen, Jan P A Baak
Published 2014-01-01

A Multiscale Approach for Whole-Slide Image Segmentation of five Tissue Classes in Urothelial Carcinoma Slides

by Rune Wetteland MS, Kjersti Engan PhD, Trygve Eftestøl PhD, Vebjørn Kvikstad MD, Emiel A. M. Janssen PhD
Published 2020-10-01

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium...

by Satu Oltedal, Ivar Skaland, Jodi Maple-Grødem, Kjersti Tjensvoll, Emiel A. M. Janssen, Bjørnar Gilje, Rune Smaaland, Reino Heikkilä, Oddmund Nordgård
Published 2018-02-01

Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.

by Kristin Jonsdottir, Susanne R Janssen, Fabiana C Da Rosa, Einar Gudlaugsson, Ivar Skaland, Jan P A Baak, Emiel A M Janssen
Published 2012-01-01

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

by Nina G. Egeland, Siri Lunde, Kristin Jonsdottir, Tone H. Lende, Deirdre Cronin-Fenton, Bjørnar Gilje, Emiel A. M. Janssen, Håvard Søiland
Published 2015-10-01

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years

by Emiel A. M. Janssen, Håvard Søiland, Ivar Skaland, Einar Gudlaugson, Kjell H. Kjellevold, Arne Nysted, Jon-Arne Søreide, Jan P. A. Baak
Published 2007-01-01

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer.

by Melinda Lillesand, Vebjørn Kvikstad, Ok Målfrid Mangrud, Einar Gudlaugsson, Bianca van Diermen-Hidle, Ivar Skaland, Jan P A Baak, Emiel A M Janssen
Published 2020-01-01

Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer

by Maret L. Maliniak, Jasmine Miller-Kleinhenz, Deirdre P. Cronin-Fenton, Timothy L. Lash, Keerthi Gogineni, Emiel A. M. Janssen, Lauren E. McCullough
Published 2021-05-01

High Frequency Microsatellite Instability Has a Prognostic Value in Endometrial Endometrioid Adenocarcinoma, But Only in FIGO Stage 1 Cases

by Anita Steinbakk, Anais Malpica, Aida Slewa, Einar Gudlaugsson, Emiel A. M. Janssen, Mark Arends, Arnold Jan Kruse, Yu Yinhua, Weiwei Feng, Jan P. Baak
Published 2010-01-01

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer

by Emiel A. M. Janssen, Irene T. Øvestad, Ivar Skaland, Håvard Søiland, Einar Gudlaugsson, Kjell H. Kjellevold, Arne Nysted, Jon-Arne Søreide, Jan P. A. Baak
Published 2009-01-01

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.

by Shay Ben-Elazar, Miriam Ragle Aure, Kristin Jonsdottir, Suvi-Katri Leivonen, Vessela N Kristensen, Emiel A M Janssen, Kristine Kleivi Sahlberg, Ole Christian Lingjærde, Zohar Yakhini
Published 2021-02-01

Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience

by Eirik Viste, Cathrine Alvaer Vinje, Torgeir Gilje Lid, Svein Skeie, Øystein Evjen-Olsen, Tobias Nordström, Olav Thorsen, Bjørnar Gilje, Emiel A. M. Janssen, Svein R. Kjosavik
Published 2020-07-01